Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 1988. Start Trial.
Date Value
December 31, 2025 -27.59M
December 31, 2024 -22.53M
December 31, 2023 -58.79M
December 31, 2022 -146.91M
December 31, 2021 -203.35M
December 31, 2020 -184.82M
December 31, 2019 -124.58M
December 31, 2018 -191.80M
December 31, 2017 -170.30M
December 31, 2016 -134.10M
December 31, 2015 -78.53M
December 31, 2014 -60.28M
December 31, 2013 -40.76M
December 31, 2012 -17.01M
December 31, 2011 -7.721M
December 31, 2010 -5.483M
December 31, 2009 -11.00M
December 31, 2008 -24.28M
December 31, 2007 -17.28M
Date Value
December 31, 2006 9.181M
December 31, 2005 -7.527M
December 31, 2004 -7.743M
December 31, 2003 -6.525M
December 31, 2002 -5.131M
December 31, 2001 -6.491M
December 31, 2000 -3.116M
December 31, 1999 -0.6472M
December 31, 1998 -1.547M
December 31, 1997 -0.0303M
December 31, 1996 -6.117M
December 31, 1995 -8.520M
December 31, 1994 -8.631M
December 31, 1993 -11.66M
December 31, 1992 -3.914M
December 31, 1991 -3.807M
December 31, 1990 -3.441M
December 31, 1989 -3.845M
December 31, 1988 -3.858M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Tonix Pharmaceuticals Holding Corp. -99.84M
ACADIA Pharmaceuticals, Inc. 109.84M
Alnylam Pharmaceuticals, Inc. 524.08M
Anika Therapeutics, Inc. 11.19M
Savara, Inc. -101.04M